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Summary
Studies were undertaken to assess the biochemical effects of dietary supplementation with n-9
eicosatrienoic acid (ETrA), an arachidonic acid analogue that is normally present in cell membranes
at very low levels but is raised in the presence of essential fatty acid deficiency (EFAD). The
incorporation ofdietary ETiA into rat neutrophils and its effect on A23187-stimulated 5-lipoxygenase
metabolism in these cells was examined; in addition, the effect of ETrA was compared with that
ofanother arachidonic acid analogue, eicosapentaenoic acid (EPA), which is known to accumulate
in cell membranes and inhibit synthesis of leukotriene B4 (LTB4), i product of the 5-lipoxygenase
metabolic pathway. Rats were fed a defined diet that was sufficient in essential fatty acids and
that contained EPA or ETrA (0.014% of energy) or no added fatty acid, for 3 wk. In the cells
from ETrA-fed rats, LTB4 synthesis was inhibited relative to control values, but synthesis of the
other products of 5-lipoxygenase metabolism, 5-hydroxyeicosatetraenoic acid (5-HETE) and the
all-trans isomers of LTB4, were not inhibited. This pattern indicates inhibition of LTA hydrolase
in ETrA-fed rats. In EPA-fed rats, there was inhibition of LTB4 and the all-trans isomers of LTB4,
but there was no inhibition of 5-HETE. This pattern indicates inhibition of LTA synthase in
EPA-fed rats. The results establish that dietary ETtA effectively inhibits synthesis of the inflammatory
mediator, LTB4, and suggest that ETrA may confer antiinflammatory benefits similar to those
observed with EFAD or dietary fish oil (which contains EPA). Because ETrA is substantially
less unsaturated than EPA, it can be expected to have greater chemical stability, which could
be an important practical advantage when used as a dietary constituent or supplement.
Activation of neutrophils and monocytes stimulates the me-
1A tabolism of arachidonic acid (C20:4 n-6; AA) via the
sequential actions of 5-lipoxygenase/LTA synthase and LTA
hydrolase to the inflammatory mediator, leukotriene B4
(LTB4) (Fig. 1). Inhibition of LTB4 synthesis remains a goal
of pharmacological antiinflammatory therapy. Since AA is
formed from a fatty acid that is abundant in the Western
diet, namely linoleic acid (C18:2 n-6; LA), a dietary strategy
to reduce n-6 fatty acid incorporation and metabolism may
achieve the goal of LTB4 inhibition. One strategy has in-
volved the use of dietary eicosapentaenoic acid (C20:5 n-3;
EPA), an n-3 fatty acid antagonist of AA incorporation
and metabolism that reduces LTB4 synthesis in rats (1) and
humans (2, 3) and reduces the signs and symptoms of inflam-
mation in rheumatoid arthritis (3, 4). Another strategy might
involve the use of an essential fatty acid deficient (EFAD)
diet which is defined by its lack of LA. Dietary LA restric-
tion in rats decreases the level of AA in cell membranes,
decreases LTB4 synthesis (5, 6), and decreases experimental
inflammation (7).
Restriction ofdietary LA greatly decreases the ratioofn-6/
n-918-carbon fatty acids available to the desaturase and elon-
gase enzymes. The decrease in its n-6 competitor results in
desaturation and elongation of oleic acid (C18:1 n-9; OA)
to 8,9,11-eicosatrienoic acid (C20:3 n-9; ETrA) (8). Like AA,
ETrA is also a substrate for 5-lipoxygenase/LTA synthase, the
initial enzyme in the leukotriene biosynthetic pathway. ETrA,
formed as a result of EFAD, is converted by 5-lipoxygen-
ase/LTA synthase to LTA3 (5) which is a poor substrate, but
a potent inhibitor of LTA hydrolase (9). LTA hydrolase, in
the presence of its usual n-6 substrate, LTA4, catalyzes LTB4
formation (Fig. 1). In EFAD rats, the decrease in LTB4 syn-
thesis (87%) was disproportionately large compared with the
decrease in AA levels (34%); therefore, LTA3 (formed from
ETrA) was thought to contribute significantly to inhibition
of LTB4 synthesis (5).
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by the substitution of monounsaturated oils and spreads for
the usual polyunsaturated products did not cause AA reduc-
tion or ETrA formation or LTB4 inhibition (10). Further
reductions in dietary LA will be difficult to achieve. How-
ever, dietary supplementation with ETrA may accomplish
LTBa inhibition if it can be incorporated into tissues and
then metabolized to an inhibitor of LTBa. This has not been
examined. In the present study, we have fed chemically syn-
thesized ETrA to rats and examined its incorporation into
neutrophils and its effect on LTBa synthesis. Its effects were
also compared with those resulting from EPA feeding.
Materials and Methods
Materials.
￿
5,8,11-Eicosatrienoic acid was chemicallysynthesized
in the Department of Organic Chemistry, Flinders University, as
described (11). After purification by crystallization, this compound
was hydrogenated to produce chromatographically pure 5,8,11-ETrA.
EPA, free acid, was a gift from Scotia Pharmaceuticals Ltd., Guild-
ford, Surrey, UK. A23187 (Sigma Chemical Co., St . Louis, MO)
was dissolved in methanol (1 mM) and diluted in aqueous buffer
immediately before use.
Animals andDiets.
￿
ETrA and EPA were dissolved (11% wt/wt)
in a mixture of vegetable oils that had a polysaturated/monosatu-
rated/saturated ratio = 0.5:1:1 and that contained added vitamin
E (0.18% wt/wt). Oils containing ETrA, EPA, or neither fatty
acid were mixed (5% wt/wt) with a fat-free diet, the composition
ofwhich has been described previously (12). The final dietary con-
tent ofETrA and EPA was 0.55% wt/wt (0.014 energy %). Groups
of 6-wk-old, male, Hooded Wistar rats (four per group) were fed
either the control diet (no ETrA or EPA) or dietscontaining ETrA
or EPA for 3 wk.
Cell Preparation and Stimulation.
￿
Peritoneal exudates were in-
duced by intraperitoneally peptone injection and after 4 h, perito-
neal exudate cells (80-90% neutrophils) were harvested by lavage
as previously described (12). Afterwashing 2x with PBS and lysing
the red blood cells with hypotonic saline, cells were resuspended
in Dulbecco's PBS (DPBS) containing glucose (1 mg/ml). The cell
number was adjusted to 106/ml. Aliquots (1 ml) of cell suspen-
sions were stimulated with A23187 (0.5 P,M) for 5 min at 37°C.
The mixtures were acidified with citric acid and, after addition
of 15-hydroxyeicosatetraenoic acid (15-HETE) as an internal stan-
dard, lipids were extracted with a chloroform/methanol mixture
as described (12). Quadruplicate samples were processed.
Measurement of5-Hydroxy FattyAcids.
￿
The lipid extract of the
stimulated cells was dried and reconstituted in methanol (50 P1).
LTB4, the all-trans isomers ofLTB4, and 5-HETE were quantified
by HPLC with UVdetection as described (12). We have established
that, under the conditions of stimulation employed in this study,
the co-oxidation products of LTB4 (20-hydroxy and 20-carboxy
LTB4) are not produced in measurable amounts (<3 ng/106 cells/5
min) in rat peritoneal exudate cells.
FattyAcids.
￿
Neutrophil phospholipids were purified on TLC.
Fatty acid methyl esters were generated by methanolysis, resolved,
and quantified by capillary GLC as previously described (13).
Results
NeutrophilPhospholipidFatty Acids.
￿
Dietary EPA and ETrA
were incorporated into neutrophils with the level ofEPA in-
corporation greater than that of ETrA (Table 1). Since the
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levels of EPA and ETrA and their elongation and desatura-
tion products were low or undetectable in cells from rats on
the control diet, their increased levels in the cells from rats
receiving fatty acid supplemented diets suggests cellular in-
corporation and metabolism of these dietary fatty acids (Table
1) . The sum of the levels of EPA and its elongation and de-
saturationproducts (20:5 n-3 + 22:5 n-3 + 22:6 n-3) is greater
than the sum of ETrA and its elongation product (20:3 n-9
+ 22:3 n-9), indicating that the neutrophil level of EPA is
greater than that of ETrA as a result of relatively greater in-
corporation rather than relatively less metabolism ofEPA by
the relevant elongase and desaturase enzymes.
The incorporation of EPA into neutrophil phospholipids
was associated with decreased AA and increased LA levels
(Table 1). By contrast, ETrA incorporation was not associated
with changes in AA or LA levels (Table 1).
Neutrophil5-Lipoxygenase Metabolites.
￿
Both EPA- and ETrA-
feeding inhibited LTBa synthesis and increased (slightly)
5-HETE synthesis (Table 2). However, these fatty acids had
different effects on the synthesis of the all-trans isomers of
LTBa. EPA feeding resulted in decreased formation of the
LTBa isomers to an extent similar to the decrease in LTBa
formation, whereas ETrA feeding had no apparent effect on
the isomers (Table 2). Decreased synthesis of LTBa without
decreased synthesis of the all-trans isomers of LTBa indicates
inhibition of LTA hydrolase since LTA4 is the common
precursor for the all-trans isomers of LTBa (formed nonen-
zymatically) and for LTB4 (via LTA hydrolase) (Fig. 1) .
Discussion
EFAD is associated with decreased inflammation in ex-
perimental glomerulonephritis in rats (7) and with decreased
nephritis and increased survival in a murine model of sys-
temic lupus erythematosus (14). Several actions relevant to
the antiinflammatory effect of EFAD have been observed, in-
cluding decreased numbers of resident tissue macrophages and
decreased macrophage migration to an inflammatory focus
(7), decreased macrophage spreading and adherence (15), and
decreased neutrophil LTB4 synthesis (5, 16). The latter al-
teration may be especially important because LTB4 acts with
vasodilator prostaglandins to induce extravasation offluid (17)
and it is a neutrophil chemotaxin and degranulating agent
(18). LTB4 may be responsible for neutrophil migration to
an inflammatory focus in the acute phase of tissue inflamma-
tion although it has been argued that it is not responsible
for the laterphaseofmonocyte migration, at least in rats (7).
The mechanism for decreased LTB4 synthesis in EFAD
may partly involve decreased availability ofthe substrate, AA.
However, neutrophil LTB4 inhibition is disproportionately
large compared with AA decrease and there is evidence of
LTA hydrolase inhibition in EFAD (5). The combination of
these observations suggests that ETrA and its product LTA3
are mainly responsible for the inhibition of neutrophil LTB4
synthesis in EFAD rats (5). However, it is apparent that not
all ofthe depression of leukocyte function in EFAD is medi-
ated by eicosanoids, as there is evidence that the impairedValues represent the mean ± SD of determinations from four rats. In each row, values with different letters are significantly different from each
other (Newman-Keuls Multiple Comparisons analysis, p <0.05). N.D., not detectable.
macrophage spreading and adherence is mediated by decreased
AA alone and not by an eicosanoid metabolite of AA (15).
From the preceding results, it is evident that cellular AA
depletion is likely to be an important, but not the only factor
responsible for the antiinflammatory effect of EFAD, which
couldbe exploited for the treatment ofhuman diseases. The-
oretically, lowering cellular AA should reduce n-6 eicosanoid
synthesis in inflammatory lesions. Reduction of cellular AA
through dietary avoidance of its n-6 precursor, LA, requires
dietary stringencies that can be achieved in rats (dietary LA
<0.1 en%) (19), but which are not feasible for free-living
humansubjects. An alternative strategy ofusing dietary ETrA
Table 2.
￿
Effect of Dietary EPA and ETrA on the Synthesis of
5-Lipoxygenase Products by Rat Neutrophils
Values represent the mean ± SD of determinations (in quadruplicate)
from four rats. in each column, values with different letters are significantly
different from each other (Newman-Keuls Multiple Comparisions analy-
sis, p <0.05).
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supplements may confer some of the andinflammatorybenefits
of EFAD if cellular ETrA is increased to an extent that alters
leukocyte eicosanoid synthesis (and perhaps other properties).
The general approach of using unsaturated 20-carbon fatty
acids that compete directly with AA for incorporation into
cell membranes and/or compete with AA for eicosanoid syn-
thesis forms the basis for usingfish oil or EPA to inhibit n-6
eicosanoid synthesis. However, the current study is the first
attempt (to our knowledge) to evaluate this strategy with
n-9 fatty acids and the results indicate that dietary ETrA is
incorporated into leukocyte membranes. While no decrease
in AA level was seen, LTB4 synthesis was inhibited and as
discussed below, the ratio of AA to 20-carbon fatty acid com-
petitors (ETrA and EPA) may be a principal determinant of
the effect of these competitors on eicosanoid synthesis.
We have previously shown a correlation between EPA/AA
ratios in rat neutrophils and LTBs/LTB4 synthesis (1, 12, 13)
in rats fed diets of varying n-3 and n-6 fatty acid content.
Using data from the present study and published studies that
used rat peritoneal exudate cells, it is possible to examine the
relationship between ETrA/AA ratios in rat neutrophils and
LTB4 synthesis. In the present study, ETrA feeding at a di-
AA
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Table 1. Effect of Dietary EPA and ETrA on Rat Neutrophil Fatty Acid Composition
Neutrophil Fatty Acids (Percent total fatty acids)
Control EPA-Fed ETrA-Fed
Total Sats 40.1 ± 0.2 a 42.3±0.6b 38.9±0.2c
Total Monos. 21.4 ± 0.4 a 19 .9±0.1b 19.6±0.2b
20:3 n-9 (ETrA) 0.5 ± 0.04 a N.D. 4.8 ± 0.1 b
22:3 n-9 N.D. N.D. 1 .4 ± 0.2
18:2 n-6 6.5 ± 0.3 a 10 .1 ± 0.3 b 6.7 ± 0.2 a
20:3 n-6 1.3 ± 0.1 a 1.0 ± 0.1 ab 0.9 ± 0.1 b
20:4 n-6 (AA) 26.1 ± 0.5 a 18.7 ± 1 .2 b 24.9 ± 0.9 a
22:4n-6 2 .2±0.1a 0.4 ± 0.1 b 1.3 ± 0.2 c
22:5 n-6 0.7 ± 0.1 a N.D. 0.5 ± 0.01 b
Total n-6 36 .8 30.2 34.3
20:5 n-3 (EPA) 0.1 ± 0.03 a 7.0 ± 0.5 b N.D.
22:5 n-3 N.D. 2 .5 ± 0.1 N.D.
22:6n-3 0.5±0.01a 2.5 ± 0.7 b 0.4 ± 0.02 a
Total n-3 0.6 12 .0 0.4
LTB4 LTB4
ng/106
Isomers
cells/5 min
5-HETE
Control 23.9 t 1 .6 a 15 .2 ± 1 .2 a 21.7 ± 1 .1 a
EPA-fed 10.3 ± 0.7 b 4.5 ± 0.3 b 26.6 ± 1.6 b
ETrA-fed 15 .2 ± 1 .1 c 16 .6 ± 1 .1 a 27.8 ± 2.5 be0
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Figure 2.
￿
Relationshipbetween the neutrophilETrA/AA ratio and the
extent of inhibition of leukotriene B4 synthesis. The source of the data
is shown beneath each symbol.
etary level of0.014 energy % resulted in a neutrophil ETWAA
ratio of 0.20 and a 36% decrease in neutrophil LTB4 syn-
thesis. In addition, it has been reported that rats maintained
on an EFAD diet for 1 yr had a neutrophil ETrA/AA ratio
of 0.59 and 87% depression of LTB4 synthesis (5) and rats
maintained on an EFAD diet for several generations had a
neutrophil ETrA/AA ratio of 0.42 and 60% depression of
LTB4 synthesis (16) . Using these data from the present study
and the published studies (5, 16), all ofwhich employed peri-
toneal elicited cells as the source ofneutrophils, a strong corre-
lation was observed between the neutrophil ETrA/AA ratio
and depression of LTB4 synthesis (r = 0.99, p = 0.005)
(Fig. 2).
Thus, the effect of cellular ETrA on LTB4 synthesis is
similar for exogenous (dietary) ETrA and endogenous (formed
during EFAD) ETrA. Another similarity in the effects of di-
etary ETrA and EFAD is the inhibition of LTA hydrolase as
manifested by decreased LTB4 synthesis with no decrease in
LTB4 isomer formation. In human neutrophils, inhibition of
LTA hydrolase is likely to be more effective than inhibition
of 5-lipoxygenase/LTA synthase for decreasing LTB4 syn-
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